$CRM

CRM

Salesforce, Inc.

All takes and content in this window

As of 09-26
09-25
Parkev Tatevosian, CFAPublished 2026-09-25
“Is it Safe to Buy Salesforce Stock Right Now? | CRM STock Analysis”
$CRMBullish
CRM is a buy; revenue growth accelerated to 13% and margins expanded, while valuation at 14.6x forward P/E remains attractive relative to historical levels.

Salesforce management informed investors that it is on track to accelerate revenue growth again in the second half of 2027 and beyond. Management also reaffirmed its goal of generating $63 billion in revenue by 2030.

This is accompanied by strong operating profit margins, which are expected to reach approximately 34% for the second half of the year and for the current fiscal year as a whole.

So, does all this make Salesforce stock a buying opportunity?

The CompoundPublished 2026-09-25
“People Hate These 5 Stocks But They'll Be Wrong | TCAF 261”
$CRMBullish
Salesforce's competitive risk from AI providers has been neutralized by partnerships (e.g., Anthropic), suggesting the stock's downside narrative is complete.

Well, you were, I think you were very optimistic about CRM. Yes. The stock had suffered a severe blow at that time, and the picture has clearly changed now. They entered into a partnership with "Anthropic" instead of being eliminated by it.

I don't think many people were feeling optimistic at that time, but you were.

Older record
09-24
T3 LivePublished 2026-09-24
“#META to $1000? LIVE with David Prince”
$CRMBullish
CRM is buyable at a good valuation (<17-18x) due to turnaround, Anthropic partnership, and seat growth.

Anyway, um so the socks because it's trading better via MU and SanDisk, which got over some important levels, Dell, CRM, um and certainly Meta.

Older record
Showing 3 / 3 on this page
See this ticker’s full history